Other research has found that knocking down NOD-like receptor (NLR) X1 (NLRX1) can suppress glycolysis and enhance fatty acid oxidation, thereby reducing hepatic steatosis [13]. This evidence concerns the gene NLRX1 and fatty liver disease.